ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,842.63
1.12%
US Tech 100
20,043.20
1.12%
다우존스 지수
43,006.59
1.14%
Bitcoin
91,742.33
1.22%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. OpGen Inc (PK) (OPGN) 시세

OpGen Inc (PK)

OpGen Inc (PK) (OPGN)

USOTC
0.73
-0.0286
(-3.77%)
마감 06 3월 6:00AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
0.73
매수가
0.66
매도가
1.10
거래량
493
0.73 일간 변동폭 0.73
0.5273 52주 범위 2.57
market_cap
7.35M
전일 종가
0.7586
개장가
0.73
최근 거래 시간
1
@
0.6884
마지막 거래 시간
재정 규모
US$ 360
VWAP
0.73
평균 볼륨(3m)
5,107
발행 주식
10,068,111
배당수익률
-
주가수익률
-0.22
주당순이익(EPS)
-3.24
매출
3.42M
순이익
-32.67M

OpGen Inc (PK) 정보

섹터
Medical Laboratories
산업
Medical Laboratories
웹사이트
www.opgen.com
본부
Wilmington, Delaware, USA
설립됨
-
OpGen Inc (PK) is listed in the Medical Laboratories sector of the OTC 시장 with ticker OPGN. The last closing price for OpGen (PK) was US$0.76. Over the last year, OpGen (PK) shares have traded in a share price range of US$ 0.5273 to US$ 2.57.

OpGen (PK) currently has 10,068,111 shares in issue. The market capitalisation of OpGen (PK) is US$7.64 million. OpGen (PK) has a price to earnings ratio (PE ratio) of -0.22.

OPGN 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
27 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
20 12월 2024
OPGN (-3.77%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.3025-29.29782082321.03251.040.7312410.81723218CS
4-0.1945-21.03839913470.92451.410.7312821.13683471CS
12-0.71-49.30555555561.441.990.527351070.93590008CS
26-1.2-62.17616580311.932.250.527339681.30842779CS
52-1.02-58.28571428571.752.570.527354961.60378526CS
156-1.02-58.28571428571.752.570.527354961.60378526CS
260-1.02-58.28571428571.752.570.527354961.60378526CS

OPGN - Frequently Asked Questions (FAQ)

What is the current OpGen (PK) share price?
The current share price of OpGen (PK) is US$ 0.73
How many OpGen (PK) shares are in issue?
OpGen (PK) has 10,068,111 shares in issue
What is the market cap of OpGen (PK)?
The market capitalisation of OpGen (PK) is USD 7.64M
What is the 1 year trading range for OpGen (PK) share price?
OpGen (PK) has traded in the range of US$ 0.5273 to US$ 2.57 during the past year
What is the PE ratio of OpGen (PK)?
The price to earnings ratio of OpGen (PK) is -0.22
What is the cash to sales ratio of OpGen (PK)?
The cash to sales ratio of OpGen (PK) is 2.15
What is the reporting currency for OpGen (PK)?
OpGen (PK) reports financial results in USD
What is the latest annual turnover for OpGen (PK)?
The latest annual turnover of OpGen (PK) is USD 3.42M
What is the latest annual profit for OpGen (PK)?
The latest annual profit of OpGen (PK) is USD -32.67M
What is the registered address of OpGen (PK)?
The registered address for OpGen (PK) is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the OpGen (PK) website address?
The website address for OpGen (PK) is www.opgen.com
Which industry sector does OpGen (PK) operate in?
OpGen (PK) operates in the MEDICAL LABORATORIES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
GSIHGeneral Steel Holdings Inc (CE)
US$ 0.10
(99,900.00%)
25.32k
AFIIQArmstrong Flooring Inc (CE)
US$ 0.0002
(19,900.00%)
300
IVRNInnoveren Scientific Inc (CE)
US$ 0.0002
(19,900.00%)
10k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(9,900.00%)
52.14M
FBCDFBC Holding Inc (PK)
US$ 0.0001
(9,900.00%)
23k
TBLTToughBuilt Industries Inc (CE)
US$ 0.000001
(-100.00%)
487
GNRSQGreenrose Holding Company Inc (CE)
US$ 0.000001
(-100.00%)
261
ELOXEloxx Pharmaceuticals Inc (CE)
US$ 0.0001
(-99.99%)
2.53k
TIGXFTeam Internet Group PLC (QX)
US$ 0.0001
(-99.99%)
100
BLIBQBB Liquidating Inc (CE)
US$ 0.000001
(-99.90%)
25k
GTVHGolden Triangle Ventures Inc (PK)
US$ 0.00035
(40.00%)
258.92M
HMBLHUMBL Inc (PK)
US$ 0.0005
(0.00%)
221.36M
GRPSGold River Productions Inc (PK)
US$ 0.0002
(-20.00%)
205.71M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
201.87M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0025
(-3.85%)
187.8M

토론

전체 피드 보기
Mrhumble59 Mrhumble59 4 분 전
Okay, I get it. Say nothing about politics and your posts stay. Good to know.
HMBL
europa7 europa7 4 분 전
‘Qatar well-placed to be global leader in decentralised technologies’
04 Mar 2025
https://thepeninsulaqatar.com/article/04/03/2025/qatar-well-placed-to-be-global-leader-in-decentralised-technologies

"...Doha, Qatar: Qatar is strategically positioning itself as a global l
HBARUSD
ORCA ORCA 5 분 전
NO BRO WE ARE GOING DOWN.BIG TIME.
VDRM
Lime Time Lime Time 6 분 전
A Form 15 is a simple one page document. A check mark and an Integer # of shareholders on record. It also costs zero dollars to file it.

Not taking the first step shows they purposely want this to get revoked.

The second red flag is not being transfer agent verified.
RSPI
solidgold solidgold 8 분 전
Where did you get it from? I like this from? I like this OTC pink odd.
NBRI
copytele copytele 8 분 전
I BOUGHT BACK IN , 1200 SHARES , HOWEVER AFTER HOURS IT SUNK .
RGTI
threewheeler threewheeler 8 분 전
AZRH fantastic https://x.com/americanmade_ai/status/1897327853173149791
AZRH
threewheeler threewheeler 8 분 전
AZRH fantastic https://x.com/americanmade_ai/status/1897327853173149791
AZRH
3331 3331 8 분 전
BIEL NEW ZEALAND SALES LAUNCHED MARCH 1!
https://www.actipatch.nz/
3331 3331 9 분 전
BIEL NEW ZEALAND SALES LAUNCHED MARCH 1!
https://www.actipatch.nz/
threewheeler threewheeler 9 분 전
AZRH fantastic https://x.com/americanmade_ai/status/1897327853173149791
AZRH
blackhawks blackhawks 9 분 전
Remember that there's a distinction between immunity from criminal prosecution and violations of Congressional authority, as spelled out in the Constitution.

One would think that the president's WH lawyer would point that out, particularly as OUR lawyer, the people's lawyer the AG, p
Acme Investments Acme Investments 9 분 전
👇 Machine you made the comment for me to Say something!! Just so you could wiggle your wrinkled finger!! I did notice that you didn't address the comment with an intelligent answer!! No one is buying 1's for the purpose you claimed!!
JAMN
axelvento axelvento 9 분 전
Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday
WINNER$ A court decision from Europe
Earlier that day, a court in Düsseldorf, Germany ruled that a COVID patent held by Moderna had been violated by a pair of rivals, American pharmaceutical giant Pfizer and its partner, German bi
MRNA
$7.00 or Nothing $7.00 or Nothing 11 분 전
20 top pharma in India.

https://builtin.com/articles/top-pharma-companies-in-india
ELTP
Whalatane Whalatane 11 분 전
Yes. OLC is a reformulation of an existing drug Fosrenol . It would surprise me if they called an Adcom. since the FDA has already agreed that OLC is the bio equivalent of Fosrenol.
My only short term concern is if DOGE cut backs will cause any delays in this final approval process.
UNCY
Grizzyman Grizzyman 11 분 전
Drill baby drill
FTXP
$7.00 or Nothing $7.00 or Nothing 12 분 전
Great article.
https://www.pharmavoice.com/news/trump-tariffs-china-generic-drug-manufacturing-reshore/734785/
ELTP
fuagf fuagf 13 분 전
LOLOL It's beautiful on the bottom ..

[yt]EF8C4v7JIbA[/yt]

For children, hatchets, lanterns...

[yt]25-Ju0y7NBo[/yt]

Even better down under when Trump is up there .. haha
bigtalan bigtalan 13 분 전
Yes a very intereting buy , I thought this board was dead , noone talking about anything. Glad to hear someone is watching. New to the board and postion. GLTA
QBTS
elks elks 14 분 전
Tic toc
GVSI
norisknorewards norisknorewards 16 분 전
We agree.
NWBO
$7.00 or Nothing $7.00 or Nothing 16 분 전
Celltrion looks to buy US facilities to sidestep potential Trump tariffs 
Anna Brown
News Reporter
South Korean biopharma contract manufacturer Celltrion is considering acquiring US manufacturing sites to mitigate President Donald Trump’s potential tariffs on foreign-made pharma
ELTP
WarMachine WarMachine 17 분 전
So very true! These GIANTS OF INDUSTRY sure are making a bad impression. How could they possibly fail to add Brian Lewis? Or did he not make it even a week? Hmmmmmm
But, at least we have Reggie
MONI

최근 히스토리

USOTC
OPGN
OpGen (PK)
BIT
WCCA
Wisdomtree California Ca...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지